P
Pacific Biosciences
Biotech & Life Sciences · Menlo Park, United States · Founded 2004 · IPO 2010
Pacific Biosciences mafia
Startups founded by Pacific Biosciences alumni
Former Pacific Biosciences employees who went on to start their own companies. Sorted by Dealroom signal score.
Tim LeeUnited States
Art PolkUnited States
Ayal HendelIsrael
David VillagraUnited States
Eric SchadtUnited States
Colleen CutcliffeUnited States
Morassa MohseniAustraliaGlobal footprint
Where Pacific Biosciences has talent and traffic
team presence
across markets
Talent graph
The shape of Pacific Biosciences's talent
Dealroom maps Pacific Biosciences's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.
Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.
Patent intelligence
$314M patent portfolio · 245 active families
Where Pacific Biosciences concentrates vs peers
Each axis is a top-10 topic across Pacific Biosciences and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Capital deployed
Pacific Biosciences's 3 investments and acquisitions.
Every disclosed deal where Pacific Biosciences appeared as a backer or acquirer, 2021–2023. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
3 deals across Pacific Biosciences's capital deployment.
Where the deals concentrate by sector, stage, and decade.
01 · Deployment strategy vs peers
Where Pacific Biosciences deploys vs peers
Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.
02 · Portfolio market map
Pacific Biosciences's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
What the market is saying about Pacific Biosciences
An AI-synthesized read of the highest-engagement posts about Pacific Biosciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Pacific Biosciences on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.